Ticker
ADAPCompany Name
ADAPTIMMUNE THERAPEUTICS PLCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earnings Yield | Market Capitalization | Net Income Common Stock |
---|---|---|---|
6/30/2025 | -819.47% | $ 20.72M | $ -169.76M |
3/31/2025 | -105.27% | $ 66.4M | $ -69.89M |
12/31/2024 | -99.19% | $ 71.4M | $ -70.81M |
9/30/2024 | -22.52% | $ 197.68M | $ -44.52M |
6/30/2024 | -25.96% | $ 279.32M | $ -72.5M |
3/31/2024 | -51.46% | $ 317.53M | $ -163.41M |
12/31/2023 | -26.93% | $ 422.92M | $ -113.87M |
9/30/2023 | -74.31% | $ 128.13M | $ -95.2M |
6/30/2023 | -47.25% | $ 192.63M | $ -91.02M |
3/31/2023 | -50.19% | $ 227.47M | $ -114.16M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Market Cap
(=) Earnings Yield
Earnings Yield for ADAPTIMMUNE THERAPEUTICS PLC is calculated as follows: Net Inc. Cmn. [ $ -122.84M ] / Market Cap [ $ 823.52M ]
(=) Earnings Yield [ -14.92% ]
Minimum
Jun 30, 2025
Maximum
Dec 31, 2020
Average
Median
filtered constituents | 3.42K |
---|---|
min | -31.79% |
max | 32.87% |
average | 0.33% |
median | 2.78% |
std | 9.82% |